Perfluoroalkyl substances in early pregnancy and risk of hypertensive disorders of pregnancy: A prospective cohort study
Background: Perfluoroalkyl substances (PFASs) were reported to be associated with hypertensive disorders of pregnancy (HDP) but the results were inconsistent and prospective data are scarce. We aimed to examine these associations in a large prospective birth cohort study in Shanghai, China. Methods:...
Main Authors: | , , , , , , , , , , , |
---|---|
Format: | Article |
Language: | English |
Published: |
Elsevier
2020-05-01
|
Series: | Environment International |
Online Access: | http://www.sciencedirect.com/science/article/pii/S016041201934293X |
id |
doaj-b10280cfd73c4954a4473c3fd3723ce2 |
---|---|
record_format |
Article |
collection |
DOAJ |
language |
English |
format |
Article |
sources |
DOAJ |
author |
Xiaona Huo Rong Huang Yuexin Gan Kai Luo Ruxianguli Aimuzi Min Nian Junjie Ao Liping Feng Ying Tian Weiye Wang Weiping Ye Jun Zhang |
spellingShingle |
Xiaona Huo Rong Huang Yuexin Gan Kai Luo Ruxianguli Aimuzi Min Nian Junjie Ao Liping Feng Ying Tian Weiye Wang Weiping Ye Jun Zhang Perfluoroalkyl substances in early pregnancy and risk of hypertensive disorders of pregnancy: A prospective cohort study Environment International |
author_facet |
Xiaona Huo Rong Huang Yuexin Gan Kai Luo Ruxianguli Aimuzi Min Nian Junjie Ao Liping Feng Ying Tian Weiye Wang Weiping Ye Jun Zhang |
author_sort |
Xiaona Huo |
title |
Perfluoroalkyl substances in early pregnancy and risk of hypertensive disorders of pregnancy: A prospective cohort study |
title_short |
Perfluoroalkyl substances in early pregnancy and risk of hypertensive disorders of pregnancy: A prospective cohort study |
title_full |
Perfluoroalkyl substances in early pregnancy and risk of hypertensive disorders of pregnancy: A prospective cohort study |
title_fullStr |
Perfluoroalkyl substances in early pregnancy and risk of hypertensive disorders of pregnancy: A prospective cohort study |
title_full_unstemmed |
Perfluoroalkyl substances in early pregnancy and risk of hypertensive disorders of pregnancy: A prospective cohort study |
title_sort |
perfluoroalkyl substances in early pregnancy and risk of hypertensive disorders of pregnancy: a prospective cohort study |
publisher |
Elsevier |
series |
Environment International |
issn |
0160-4120 |
publishDate |
2020-05-01 |
description |
Background: Perfluoroalkyl substances (PFASs) were reported to be associated with hypertensive disorders of pregnancy (HDP) but the results were inconsistent and prospective data are scarce. We aimed to examine these associations in a large prospective birth cohort study in Shanghai, China. Methods: A total of 10 PFASs were measured by high-performance liquid chromatography/tandem mass spectrometry (HPLC/MS-MS) in the plasma samples from 3220 women who were enrolled during early pregnancy and gave birth to a singleton live birth between 2013 and 2016. The outcomes included gestational hypertension (GH), preeclampsia (PE) and overall HDP. Associations of these outcomes with each PFASs were estimated by multivariable logistic regression and expressed as odd ratios (ORs) and 95% confidence intervals (95% CIs). Potential non-linear association between PFASs and HDP was examined with restricted cubic spline model. To handle the potential confounding by correlated PFASs, we applied elastic net regression (ENR) to identify independent PFASs components of outcomes. Results: Among all singleton live births, the incidence rates of GH and PE were 2.0% and 2.2%, respectively. Overall, PFASs did not show a significant and consistent pattern of the associations with GH, PE or overall HDP, both before and after controlling for potential confounders. ENR model confirmed the results that there was no independently predictive role of PFASs on GH, PE or overall HDP. Conclusions: In this large prospective cohort study, maternal plasma concentration of PFASs in early pregnancy were not associated with GH, PE or overall HDP in singleton livebirths. Keywords: Perfluoroalkyl substances, Gestational hypertension, Preeclampsia, Hypertensive disorders of pregnancy |
url |
http://www.sciencedirect.com/science/article/pii/S016041201934293X |
work_keys_str_mv |
AT xiaonahuo perfluoroalkylsubstancesinearlypregnancyandriskofhypertensivedisordersofpregnancyaprospectivecohortstudy AT ronghuang perfluoroalkylsubstancesinearlypregnancyandriskofhypertensivedisordersofpregnancyaprospectivecohortstudy AT yuexingan perfluoroalkylsubstancesinearlypregnancyandriskofhypertensivedisordersofpregnancyaprospectivecohortstudy AT kailuo perfluoroalkylsubstancesinearlypregnancyandriskofhypertensivedisordersofpregnancyaprospectivecohortstudy AT ruxianguliaimuzi perfluoroalkylsubstancesinearlypregnancyandriskofhypertensivedisordersofpregnancyaprospectivecohortstudy AT minnian perfluoroalkylsubstancesinearlypregnancyandriskofhypertensivedisordersofpregnancyaprospectivecohortstudy AT junjieao perfluoroalkylsubstancesinearlypregnancyandriskofhypertensivedisordersofpregnancyaprospectivecohortstudy AT lipingfeng perfluoroalkylsubstancesinearlypregnancyandriskofhypertensivedisordersofpregnancyaprospectivecohortstudy AT yingtian perfluoroalkylsubstancesinearlypregnancyandriskofhypertensivedisordersofpregnancyaprospectivecohortstudy AT weiyewang perfluoroalkylsubstancesinearlypregnancyandriskofhypertensivedisordersofpregnancyaprospectivecohortstudy AT weipingye perfluoroalkylsubstancesinearlypregnancyandriskofhypertensivedisordersofpregnancyaprospectivecohortstudy AT junzhang perfluoroalkylsubstancesinearlypregnancyandriskofhypertensivedisordersofpregnancyaprospectivecohortstudy |
_version_ |
1724698766988017664 |
spelling |
doaj-b10280cfd73c4954a4473c3fd3723ce22020-11-25T03:00:20ZengElsevierEnvironment International0160-41202020-05-01138Perfluoroalkyl substances in early pregnancy and risk of hypertensive disorders of pregnancy: A prospective cohort studyXiaona Huo0Rong Huang1Yuexin Gan2Kai Luo3Ruxianguli Aimuzi4Min Nian5Junjie Ao6Liping Feng7Ying Tian8Weiye Wang9Weiping Ye10Jun Zhang11MOE-Shanghai Key Laboratory of Children’s Environmental Health, Xinhua Hospital, Shanghai Jiao Tong University School of Medicine. 1665 Kong Jiang Road, Shanghai 200092, ChinaMOE-Shanghai Key Laboratory of Children’s Environmental Health, Xinhua Hospital, Shanghai Jiao Tong University School of Medicine. 1665 Kong Jiang Road, Shanghai 200092, ChinaMOE-Shanghai Key Laboratory of Children’s Environmental Health, Xinhua Hospital, Shanghai Jiao Tong University School of Medicine. 1665 Kong Jiang Road, Shanghai 200092, ChinaMOE-Shanghai Key Laboratory of Children’s Environmental Health, Xinhua Hospital, Shanghai Jiao Tong University School of Medicine. 1665 Kong Jiang Road, Shanghai 200092, China; School of Public Health, Shanghai Jiao Tong University School of Medicine, 227 South Chongqing Road, Shanghai 200052, ChinaMOE-Shanghai Key Laboratory of Children’s Environmental Health, Xinhua Hospital, Shanghai Jiao Tong University School of Medicine. 1665 Kong Jiang Road, Shanghai 200092, China; School of Public Health, Shanghai Jiao Tong University School of Medicine, 227 South Chongqing Road, Shanghai 200052, ChinaMOE-Shanghai Key Laboratory of Children’s Environmental Health, Xinhua Hospital, Shanghai Jiao Tong University School of Medicine. 1665 Kong Jiang Road, Shanghai 200092, China; School of Public Health, Shanghai Jiao Tong University School of Medicine, 227 South Chongqing Road, Shanghai 200052, ChinaMOE-Shanghai Key Laboratory of Children’s Environmental Health, Xinhua Hospital, Shanghai Jiao Tong University School of Medicine. 1665 Kong Jiang Road, Shanghai 200092, ChinaMOE-Shanghai Key Laboratory of Children’s Environmental Health, Xinhua Hospital, Shanghai Jiao Tong University School of Medicine. 1665 Kong Jiang Road, Shanghai 200092, ChinaMOE-Shanghai Key Laboratory of Children’s Environmental Health, Xinhua Hospital, Shanghai Jiao Tong University School of Medicine. 1665 Kong Jiang Road, Shanghai 200092, China; School of Public Health, Shanghai Jiao Tong University School of Medicine, 227 South Chongqing Road, Shanghai 200052, ChinaMOE-Shanghai Key Laboratory of Children’s Environmental Health, Xinhua Hospital, Shanghai Jiao Tong University School of Medicine. 1665 Kong Jiang Road, Shanghai 200092, ChinaDepartment of Obstetrics and Gynecology, Xinhua Hospital, Shanghai Jiao Tong University School of Medicine, 1665 Kong Jiang Road, Shanghai 200092, China; Corresponding authors at: Xinhua Hospital, Shanghai Jiao Tong University School of Medicine, 1665 Kong Jiang Road, Shanghai 200092, China (J. Zhang).MOE-Shanghai Key Laboratory of Children’s Environmental Health, Xinhua Hospital, Shanghai Jiao Tong University School of Medicine. 1665 Kong Jiang Road, Shanghai 200092, China; School of Public Health, Shanghai Jiao Tong University School of Medicine, 227 South Chongqing Road, Shanghai 200052, China; Corresponding authors at: Xinhua Hospital, Shanghai Jiao Tong University School of Medicine, 1665 Kong Jiang Road, Shanghai 200092, China (J. Zhang).Background: Perfluoroalkyl substances (PFASs) were reported to be associated with hypertensive disorders of pregnancy (HDP) but the results were inconsistent and prospective data are scarce. We aimed to examine these associations in a large prospective birth cohort study in Shanghai, China. Methods: A total of 10 PFASs were measured by high-performance liquid chromatography/tandem mass spectrometry (HPLC/MS-MS) in the plasma samples from 3220 women who were enrolled during early pregnancy and gave birth to a singleton live birth between 2013 and 2016. The outcomes included gestational hypertension (GH), preeclampsia (PE) and overall HDP. Associations of these outcomes with each PFASs were estimated by multivariable logistic regression and expressed as odd ratios (ORs) and 95% confidence intervals (95% CIs). Potential non-linear association between PFASs and HDP was examined with restricted cubic spline model. To handle the potential confounding by correlated PFASs, we applied elastic net regression (ENR) to identify independent PFASs components of outcomes. Results: Among all singleton live births, the incidence rates of GH and PE were 2.0% and 2.2%, respectively. Overall, PFASs did not show a significant and consistent pattern of the associations with GH, PE or overall HDP, both before and after controlling for potential confounders. ENR model confirmed the results that there was no independently predictive role of PFASs on GH, PE or overall HDP. Conclusions: In this large prospective cohort study, maternal plasma concentration of PFASs in early pregnancy were not associated with GH, PE or overall HDP in singleton livebirths. Keywords: Perfluoroalkyl substances, Gestational hypertension, Preeclampsia, Hypertensive disorders of pregnancyhttp://www.sciencedirect.com/science/article/pii/S016041201934293X |